This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
WEDNESDAY, April 9, 2025 -- Prescribing medical cannabis to patients with chron...
WEDNESDAY, April 9, 2025 -- Low low-density lipoprotein cholesterol (LDL-C) lev...
WEDNESDAY, April 9, 2025 -- Excessive use of overtime and agency nurse hours ar...
WEDNESDAY, April 9, 2025 -- Commercial administrative claims data reveal slight...
WEDNESDAY, April 9, 2025 -- When applied to cardiac implantable electronic devi...
WEDNESDAY, April 9, 2025 -- The risk for long COVID among pregnant individuals ...
WEDNESDAY, April 9, 2025 -- Tolebrutinib, a brain-penetrant and bioactive Bruto...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome, Annexon ...
In its first full year on the U.S. market, bladder cancer treatment Adstiladrin ...
Caris' MI Cancer Seek assay, greenlit by the FDA in November, examines 228 tumor...
Reckitt Beckiser and Organon are laying off employees in New Jersey as both comp...
Looking to get its earnings out early, PacBio posted preliminary revenue estimat...
List of industry subject matter experts and list of planned calls for industry s...
Looking to get its earnings out early, PacBio posted preliminary revenue estimat...
AstraZeneca has been busy in recent years picking up a shopping list of assets a...
On Monday, a federal judge permanently blocked the National Institutes of Health...
A New York City federal court has dismissed a proposed class action lawsuit agai...
On his MAHA Tour, Robert F. Kennedy Jr. plays up victories in fluoridation and n...
While the omission of pharmaceuticals from President Donald Trump’s much-anticip...
The Trump administration’s effort to slash federal funding to universities has f...
Shares in many large drugmakers fell Wednesday on the president's threat, which ...
Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, ...
Minutes of the PRAC meeting 10-13 February 2025
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Dat...